Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
TMCI

TMCI - Treace Medical Concepts, Inc. Stock Price, Fair Value and News

$2.40-0.14 (-5.51%)
Market Closed

72/100

TMCI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

72/100

TMCI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$3.62

Target 3M

$2.81

Target 6M

$3.06

TMCI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TMCI Price Action

Last 7 days

-8.0%

Last 30 days

-2.4%

Last 90 days

-62.2%

Trailing 12 Months

-74.6%

TMCI RSI Chart

TMCI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TMCI Valuation

Market Cap

152.9M

Price/Earnings (Trailing)

-3.05

Price/Sales (Trailing)

0.7

Price/Free Cashflow

-5.8

TMCI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$3.62

Target 3M

$2.81

Target 6M

$3.06

TMCI Fundamentals

TMCI Revenue

Revenue (TTM)

218.9M

Rev. Growth (Yr)

11.37%

Rev. Growth (Qtr)

5.97%

TMCI Earnings

Earnings (TTM)

-50.1M

Earnings Growth (Yr)

-6.04%

Earnings Growth (Qtr)

6.38%

TMCI Profitability

Return on Equity

-56.18%

Return on Assets

-25.49%

Free Cashflow Yield

-17.23%

TMCI Investor Care

Shares Dilution (1Y)

2.28%

Diluted EPS (TTM)

-0.8

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025210.8M213.8M218.9M0
2024196.0M198.5M202.9M209.4M
2023155.0M167.0M174.7M187.1M
2022104.8M114.1M125.5M141.8M
202164.8M77.7M85.1M94.4M
202043.9M48.4M52.9M57.4M
201900039.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Treace Medical Concepts, Inc.

TMCI
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
 CEO
 WEBSITEtreace.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES423

Treace Medical Concepts, Inc. Frequently Asked Questions

TMCI is the stock ticker symbol of Treace Medical Concepts, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Treace Medical Concepts, Inc. is 152.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check TMCI's fair value in chart for subscribers.

The fair value guage provides a quick view whether TMCI is over valued or under valued. Whether Treace Medical Concepts, Inc. is cheap or expensive depends on the assumptions which impact Treace Medical Concepts, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TMCI.

As of Wed Jan 28 2026, TMCI's PE ratio (Price to Earnings) is -3.05 and Price to Sales (PS) ratio is 0.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TMCI PE ratio will change depending on the future growth rate expectations of investors.